Somatropin preparation
Tevagen
By Tevagen
Available to order
Tevagen is displayed as a somatropin kit with a total printed declaration of 100 IU / 33.3 mg. The carton lists ten somatropin vials and ten separate 1 mL bacteriostatic-water vials. Ingredient shown: SomatropinPack shown: 10 product vials + 10 diluent vialsStrength marking: 100 IU / 33.3 mg total Packaging-based...
Read full detailsReference MOCK-TEVAGENSOMATROPIN100IU333MGKIT
Carton-declared pack information
Scientifically sourced molecule context
Published literature links
Batch testing not verified
Quick facts.
The full story.
Tevagen is displayed as a somatropin kit with a total printed declaration of 100 IU / 33.3 mg. The carton lists ten somatropin vials and ten separate 1 mL bacteriostatic-water vials.
Ingredient shown: Somatropin
Pack shown: 10 product vials + 10 diluent vials
Strength marking: 100 IU / 33.3 mg total
Packaging-based mockup information. Product authenticity and batch testing have not been independently verified.
Product identity and label declaration
Tevagen is shown as 100 IU / 33.3 mg total; 10 vials plus 10 labeled diluent vials. The carton states a 100 IU/33.3 mg set with 10 somatropin vials and 10 bacteriostatic-water vials. The contents of individual vials cannot be tested from a photograph.
Molecule and formulation context
Somatropin refers to the 191-amino-acid recombinant form of human growth hormone. This scientific identifier applies to the reference protein, not as authentication of the pictured contents.
How to read strength and pack size
The supplied illustration states 100 IU / 33.3 mg total; 10 vials plus 10 labeled diluent vials. A label amount indicates how the carton presents the product; it does not indicate independent potency testing. Different pack totals and per-unit declarations should not be treated as interchangeable.
What this information does not verify
The illustrated carton and public scientific sources do not establish source authenticity, regulatory approval, laboratory assay, sterility, contaminant screening, expiration or lot-matched certification. Use source documents for those claims.
Why molecular references are provided
UniProt GH1 and published receptor-signaling reviews add depth beyond packaging: they explain the human growth hormone reference structure and the GH receptor–STAT5b–IGF-I research framework.
Specifications.
Technical data.
What’s included.
Components & details.
Somatropin
Recombinant human growth hormone (reference protein)
- Reference length
- 191 amino acids
- Reference molecular mass
- ≈22 kDa
- Reference protein
- UniProt P01241
- Encoded by
- GH1 gene
- Reference receptor
- Growth hormone receptor (GHR)
- Literature context
- JAK2 / STAT5b / IGF-I signaling
- Carton declaration
- Somatropin (rDNA, 191 amino acids stated on carton)
- Carton pack format
- 100 IU / 33.3 mg total; 10 vials plus 10 labeled diluent vials
Reference somatropin is the 191-residue human growth hormone protein. Receptor signaling and IGF-I regulation are documented in published literature; none of these reference properties authenticates the pictured product.
Scientific references concern the named reference molecule or ingredient class, not this illustrated package. No verified certificate, batch assay, accreditation, purity, contamination screening, lot date or approval is claimed.
Methods & standards.
Sources & context.
Published references add scientific depth beyond the packaging. They describe reference molecules and physiological or analytical research, not independent tests or clinical advice for this particular pack.
4 topics · 3 source records
191-residue human growth hormone
Recombinant somatropin is the 191-amino-acid form of human growth hormone, with an approximately 22 kDa molecular mass. This describes the reference molecule, not an assay of the product pictured.
Growth hormone receptor signaling
Growth hormone binds its cell-surface receptor and activates signaling involving JAK2 and STAT-family transcription factors; the referenced reviews describe these pathways in physiological systems.
STAT5b and IGF-I gene expression
A principal growth hormone pathway involves STAT5b and regulation of IGF-I transcription. These are published pathway findings, not batch-specific performance data.
Literature is not verification of a commercial pack
Citations discuss growth hormone generally. They do not establish the origin, identity, sterility, potency, regulatory approval or authenticity of the pictured carton.
Complete source list (3)
Chia DJ· Molecular Endocrinology
Rotwein P· Trends in Endocrinology & Metabolism
Dehkhoda F et al.· Frontiers in Endocrinology